Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

Trial ID or NCT#

NCT06080061

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer. Depending on the location and size of the tumor.

Official Title

Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Contact us to find out if this trial is right for you.

Contact

Alyssa Yauger
650-498-5271

SEND MESSAGE

View on ClinicalTrials.gov